Atossa Therapeutics Inc. (ATOS)
NASDAQ: ATOS
· Real-Time Price · USD
0.78
-0.00 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
0.80
2.34%
After-hours: Aug 15, 2025, 07:37 PM EDT
Atossa Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.42M | -6.72M | -6.35M | -7.23M | -6.05M | -5.88M | -7.75M | -6.23M | -9.83M | -6.28M | -7.49M | -8.01M | -6.67M | -4.79M | -4.83M | -5.2M | -7.04M | -3.54M |
Depreciation & Amortization | 4K | 4K | 4K | 4K | 4K | 5K | 14K | 3K | 3K | 3K | 2K | 2K | 2K | 2K | 1.74K | 6.22K | 5.79K | 9.26K |
Stock-Based Compensation | 796K | 563K | 774K | 749K | 352K | 417K | 519K | 926K | 1.6M | 1.57M | 1.54M | 1.67M | 1.77M | 1.81M | 1.62M | 1.79M | 1.21M | 639.75K |
Other Working Capital | n/a | -294K | -604K | -2.42M | 1.33M | 332K | -1.01M | 1.01M | 1.19M | 1.52M | 109K | 1.33M | -1.51M | -1.78M | -1.5M | 205.18K | 667.44K | -653.39K |
Other Non-Cash Items | 364K | n/a | 4K | 3.64M | 2K | 2K | n/a | 527K | 2.99M | 3.1M | -599K | 2K | 1K | 1.53M | -1.16M | 1.79M | 1.51M | 1.61M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -527K | n/a | -3.1M | 599K | n/a | n/a | n/a | 1.16M | n/a | n/a | n/a |
Change in Working Capital | n/a | 192K | -1.49M | -1.92M | 1.16M | 756K | 1.65M | 1.42M | 769K | -2.32M | 1.42M | 932K | -1.05M | -1.9M | -454.6K | 335.25K | 483.07K | -1.52M |
Operating Cash Flow | -7.26M | -5.96M | -7.05M | -4.75M | -4.53M | -4.7M | -5.57M | -3.88M | -4.46M | -7.02M | -4.52M | -5.41M | -5.95M | -4.88M | -3.67M | -3.06M | -5.34M | -4.41M |
Capital Expenditures | n/a | -9K | n/a | -10K | -3K | -6K | n/a | -1K | -13K | n/a | -8K | -6K | n/a | -13K | 396.00 | -9.4K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2M | -2.7M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2K | -2.7K | n/a | -13K | -9K | n/a | n/a | n/a |
Investing Cash Flow | n/a | -9K | n/a | -10K | -3K | -6K | n/a | -1K | -13K | n/a | -2.01M | -2.71M | n/a | -13K | 396.00 | -9.4K | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.48M | n/a | n/a | n/a | 10.04M | 8.9M | n/a | n/a | n/a | 5.99M | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.87K | -574.87K | 10.2M | 32.76M |
Financial Cash Flow | n/a | n/a | 3.37M | n/a | 100K | 204K | n/a | -1.48M | n/a | n/a | n/a | n/a | n/a | n/a | 718.00 | 678.93K | 10.2M | 102.43M |
Net Cash Flow | -7.26M | -5.97M | -3.68M | -4.76M | -4.43M | -4.5M | -5.57M | -5.36M | -4.48M | -7.02M | -6.48M | -8.17M | -5.95M | -4.89M | -3.66M | -2.39M | 4.86M | 98.02M |
Free Cash Flow | -7.26M | -5.97M | -7.05M | -4.76M | -4.53M | -4.7M | -5.57M | -3.88M | -4.48M | -7.02M | -4.53M | -5.42M | -5.95M | -4.89M | -3.67M | -3.07M | -5.34M | -4.41M |